Germantown, TN, United States of America

Yali He

Average Co-Inventor Count = 5.2

ph-index = 11

Forward Citations = 642(Granted Patents)

Forward Citations (Not Self Cited) = 496(Sep 21, 2024)

Location History:

  • Florence, SC (US) (2002 - 2006)
  • Germantown, TN (US) (2007 - 2024)


Years Active: 2002-2025

where 'Filed Patents' based on already Granted Patents

32 patents (USPTO):

Title: Yali He: Innovator in Selective Androgen Receptor Degraders

Introduction

Yali He, based in Germantown, TN, is a prolific inventor with an impressive portfolio of 31 patents. His innovations primarily focus on selective androgen receptor degraders (SARD), showcasing his dedication to advancing medical treatments for serious conditions such as various types of cancer.

Latest Patents

Among his latest patents, Yali He has developed selective androgen receptor degrader (SARD) ligands and methods of use that are aimed at treating prostate cancer, advanced prostate cancer, castration-resistant prostate cancer, and triple negative breast cancer. These inventions involve complex compounds based on pyrrole, pyrazole, imidazole, triazole, and morpholine, specifically targeting the androgen receptor and its variants that can contribute to resistance against treatments. His work also addresses other hyperandrogenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, illustrating the wide-ranging implications of his research.

Career Highlights

Yali He has contributed his expertise to reputable organizations, including the University of Tennessee Research Foundation and GTx Corporation. His tenure at these institutions has enabled him to further his research and innovation in the field of pharmacology and oncology.

Collaborations

Throughout his career, Yali has collaborated with notable professionals such as Duane Douglas Miller and James T Dalton. These partnerships have likely contributed to his successful patent applications and the advancement of innovative treatments.

Conclusion

Yali He stands out as a significant contributor to the field of medical research, particularly through his work on selective androgen receptor degraders. With a strong record of patents and influential collaborations, he is paving the way for new therapeutic options in treating cancer and other critical health issues. His continued commitment to innovation promises to have a lasting impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…